help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2002-0410
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruemmer, D.
Right arrow Articles by Law, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruemmer, D.
Right arrow Articles by Law, R. E.
Molecular Endocrinology 17 (6): 1005-1018
Copyright © 2003 by The Endocrine Society

Peroxisome Proliferator-Activated Receptor {gamma} Inhibits Expression of Minichromosome Maintenance Proteins in Vascular Smooth Muscle Cells

Dennis Bruemmer, Fen Yin, Joey Liu, Joel P. Berger, Tohru Kiyono, Jasmine Chen, Eckart Fleck, Andre J. Van Herle, Barry M. Forman and Ronald E. Law

Division of Endocrinology, Diabetes and Hypertension and The Gonda (Goldschmied) Diabetes Center (D.B., F.Y., J.L., A.J.V.H., R.E.L.), David Geffen School of Medicine, University of California, Los Angeles, California 90095; Department of Medicine/Cardiology (D.B., E.F.), German Heart Institute, Berlin, D-13353, Germany; Merck Research Laboratories (J.P.B.), Rahway, New Jersey 07065; Virology Division (T.K.), National Cancer Center Research Institute, Tokyo,104-0045, Japan; and Division of Molecular Medicine and The Gonda Diabetes and Genetic Research Center, and the Department of Diabetes, Endocrinology, and Metabolism (J.C., B.M.F.), The City of Hope National Medical Center, Beckman Research Institute, Duarte, California 91010

Address all correspondence and requests for reprints to: Ronald E. Law, Ph.D, University of California, Los Angeles School of Medicine, Division of Endocrinology, Diabetes and Hypertension, Warren Hall, Suite 24-130, 900 Veteran Avenue, Los Angeles, California 90095. E-mail: rlaw{at}mednet.ucla.edu.

Using a cDNA array consisting only of cell cycle genes, we found that a novel nonthiazolidinedione partial peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) agonist (nTZDpa) inhibited expression of minichromosome maintenance (MCM) proteins 6 and 7 in vascular smooth muscle cells. MCM proteins are required for the initiation and elongation stages of DNA replication and are regulated by the transcription factor E2F. Mitogen-induced MCM6 and MCM7 mRNA expression was potently inhibited by nTZDpa and to a lesser degree by the full PPAR{gamma} agonist, rosiglitazone. Inhibition of MCM6 and MCM7 expression by nTZDpa and rosiglitazone paralleled their effect to inhibit phosphorylation of the retinoblastoma protein and cell proliferation. Transient transfection experiments revealed that the nTZDpa inhibited mitogen-induced MCM6 and MCM7 promoter activity, implicating a transcriptional mechanism. Adenoviral-mediated E2F overexpression reversed the suppressive effect of nTZDpa on MCM6 and MCM7 expression. Furthermore, activity of a luciferase reporter plasmid driven by multiple E2F elements was inhibited by nTZDpa, indicating that their down-regulation by nTZDpa involves an E2F-dependent mechanism. Overexpression of dominant-negative PPAR{gamma} or addition of a PPAR{gamma} antagonist, GW 9662, blocked nTZDpa inhibition of MCM7 transcription. Adenovirus-mediated overexpression of constitutively active PPAR{gamma} inhibited MCM7 expression in a similar manner as the nTZDpa. These findings provide strong evidence that activation of PPAR{gamma} attenuates MCM7 transcription and support the important role of this nuclear receptor in regulating vascular smooth muscle cell proliferation.

NURSA Molecule Pages Link:

Nuclear Receptors:   PPARγ
Ligands:   GW 9662  |  Rosiglitazone



This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Meredith, M. Panchatcharam, S. Miriyala, Y.-S. Tsai, A. J. Morris, N. Maeda, G. A. Stouffer, and S. S. Smyth
Dominant-Negative Loss of PPAR{gamma} Function Enhances Smooth Muscle Cell Proliferation, Migration, and Vascular Remodeling
Arterioscler. Thromb. Vasc. Biol., April 1, 2009; 29(4): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. L. Schiffrin and P. Paradis
Suppression of Peroxisome Proliferator-Activated Receptor-{gamma} Activity by Angiotensin II in Vascular Smooth Muscle Involves Bcr Kinase: The Fire That Drowns The Water
Circ. Res., January 2, 2009; 104(1): 4 - 6.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nomiyama, T. Nakamachi, F. Gizard, E. B. Heywood, K. L. Jones, N. Ohkura, R. Kawamori, O. M. Conneely, and D. Bruemmer
The NR4A Orphan Nuclear Receptor NOR1 Is Induced by Platelet-derived Growth Factor and Mediates Vascular Smooth Muscle Cell Proliferation
J. Biol. Chem., November 3, 2006; 281(44): 33467 - 33476.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Ogawa, T. Nomiyama, T. Nakamachi, E. B. Heywood, J. F. Stone, J. P. Berger, R. E. Law, and D. Bruemmer
Activation of Peroxisome Proliferator-Activated Receptor {gamma} Suppresses Telomerase Activity in Vascular Smooth Muscle Cells
Circ. Res., April 14, 2006; 98(7): e50 - e59.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. S. Kim, J. A. Franklyn, A. L. Stratford, K. Boelaert, J. C. Watkinson, M. C. Eggo, and C. J. McCabe
Pituitary Tumor-Transforming Gene Regulates Multiple Downstream Angiogenic Genes in Thyroid Cancer
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1119 - 1128.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Blaschke, O. Leppanen, Y. Takata, E. Caglayan, J. Liu, M. C. Fishbein, K. Kappert, K. I. Nakayama, A. R. Collins, E. Fleck, et al.
Liver X Receptor Agonists Suppress Vascular Smooth Muscle Cell Proliferation and Inhibit Neointima Formation in Balloon-Injured Rat Carotid Arteries
Circ. Res., December 10, 2004; 95(12): e110 - e123.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. A. Hsueh and D. Bruemmer
Peroxisome Proliferator-Activated Receptor {gamma}: Implications for Cardiovascular Disease
Hypertension, February 1, 2004; 43(2): 297 - 305.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
Y. Tani, R. R. Maronpot, J. F. Foley, J. K. Haseman, N. J. Walker, and A. Nyska
Follicular Epithelial Cell Hypertrophy Induced by Chronic Oral Administration of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Female Harlan Sprague--Dawley Rats
Toxicol Pathol, January 1, 2004; 32(1): 41 - 49.
[Abstract] [PDF]


Home page
Circ. Res.Home page
D. Bruemmer, F. Yin, J. Liu, J. P. Berger, T. Sakai, F. Blaschke, E. Fleck, A. J. Van Herle, B. M. Forman, and R. E. Law
Regulation of the Growth Arrest and DNA Damage-Inducible Gene 45 (GADD45) by Peroxisome Proliferator-Activated Receptor {gamma} in Vascular Smooth Muscle Cells
Circ. Res., August 22, 2003; 93 (4): e38 - e47.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society